Company: INDP
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-021759
Chunk: 0

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
INDAPTUS
THERAPEUTICS, INC.

Unaudited
Condensed Consolidated Balance Sheets

    September 30, 2025  
    December 31, 2024 
  
    Assets 

    Current assets: 

    Cash and cash equivalents 
    $5,825,639  
    $5,786,753 
  
    Prepaid expenses and other current assets 
     613,354  
     831,577 

    Total current assets 
     6,438,993  
     6,618,330 

    Non-current assets: 

    Right-of-use asset 
     8,487  
     82,175 
  
    Other assets - deposits to third parties 
     392,572  
     638,251 

    Total non-current assets 
     401,059  
     720,426 

    Total assets 
    $6,840,052  
    $7,338,756 

    Liabilities and stockholders’ equity 

    Current liabilities: 

    Accounts payable and other current liabilities 
    $2,225,639  
    $3,309,717 
  
    Operating lease liability, current portion 
     8,686  
     84,164 

    Total current liabilities 
     2,234,325  
     3,393,881 

    Commitments and contingencies (Note 8) 
     -  
     - 

    Stockholders’ equity: 

    Common stock: $0.01 par value,
    200,000,000 shares authorized as of September
    30, 2025 and December 31, 2024; 1,641,920
    shares issued and outstanding as of September 30, 2025 and 428,799
    shares issued and outstanding as of December 31, 2024* 
     16,420  
     4,288 
  
    Preferred stock: $0.01 par value, 5,000,000 shares authorized as of September 30, 2025 and December 31, 2024; no shares issued or outstanding 
     -  
     - 
  
    Additional paid in capital* 
     77,764,956  
     64,379,770 
  
    Accumulated deficit